Novo Nordisk Foundation logo
Investigator Initiated Clinical Trials

Investigator Initiated Clinical Trials

Supports Danish hospital teams with non-commercial clinical trials to improve patient care.

OpenNovo Nordisk FoundationDenmark

The Novo Nordisk Foundation's Investigator Initiated Clinical Trials programme funds larger non-commercial clinical trials anchored at Danish hospitals, with the explicit goal of improving patient treatment through rigorous evidence from new medicines, technologies, or care routines. Both monocentric and multicenter national trials are eligible; for multicenter international trials, the coordinati…

Funds larger non-commercial clinical trials with patients in Denmark — randomised and non-randomised — aimed at improving treatment routines through new medicines or technologies, anchored at Danish hospitals.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.—
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.36–60 months
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.DKK 89M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see the timeline

Last verified: 29 Jul 2026Source: novonordiskfonden.dk